<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Omnibus Archives - Esprimi</title>
	<atom:link href="https://esprimi.eu/tag/omnibus/feed/" rel="self" type="application/rss+xml" />
	<link></link>
	<description></description>
	<lastBuildDate>Thu, 12 Dec 2024 13:51:21 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://esprimi.eu/wp-content/uploads/2018/04/cropped-site-icon-esprimi-final-01-e1524641515998-1-32x32.png</url>
	<title>Omnibus Archives - Esprimi</title>
	<link></link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Nearly 4 in 5 Maltese nationals intend to take the COVID-19 vaccine</title>
		<link>https://esprimi.eu/2020/12/28/nearly-4-in-5-maltese-nationals-intend-to-take-the-covid-19-vaccine/</link>
		
		<dc:creator><![CDATA[Esprimi]]></dc:creator>
		<pubDate>Mon, 28 Dec 2020 12:58:09 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Omnibus]]></category>
		<category><![CDATA[Esprimi]]></category>
		<category><![CDATA[Market Research]]></category>
		<guid isPermaLink="false">https://esprimi.wpenginepowered.com/?p=4344</guid>

					<description><![CDATA[<p>Results from our latest Omnibus study finds 70.8% Maltese nationals intend to take the COVID-19 vaccine.</p>
<p>The post <a href="https://esprimi.eu/2020/12/28/nearly-4-in-5-maltese-nationals-intend-to-take-the-covid-19-vaccine/">Nearly 4 in 5 Maltese nationals intend to take the COVID-19 vaccine</a> appeared first on <a href="https://esprimi.eu">Esprimi</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="et_pb_section et_pb_section_0 et_section_regular" >
				
				
				
				
				
				
				<div class="et_pb_row et_pb_row_0">
				<div class="et_pb_column et_pb_column_4_4 et_pb_column_0  et_pb_css_mix_blend_mode_passthrough et-last-child">
				
				
				
				
				<div class="et_pb_module et_pb_text et_pb_text_0  et_pb_text_align_left et_pb_bg_layout_light">
				
				
				
				
				<div class="et_pb_text_inner"><p>Results from our latest Omnibus study finds 70.8% (nearly 4 in 5) Maltese nationals intend to take the COVID-19 vaccination. Of the 500 respondents surveyed, 38% responded “definitely” and 32.8% “rather likely”. Another 10.8% percent said “not likely” and 4.6% “definitely not”. The remaining 13.8% of respondents said they did not know.</p>
<p>Almost 1 out of 4 respondents were still undecided/hesitant about taking the vaccine, but male respondents were more likely (72.9%) to say they would take the vaccine than female respondents (68.9%). In fact, indecisiveness about whether to take the vaccine was higher amongst women than men. Women were also more likely to say they would “definitely” not take the vaccine. Of those 4.6% who stated they will “definitely” not take the vaccine, 60.9% were women and 39.1% were men.</p>
<p>The respondents who claimed were still undecided about taking the vaccine, expressed that this was mostly due to the potential side effects (45.2%), followed by their apprehension towards the fast development of the virus and uncertainty about testing (31.5%).</p>
<p>The age group most likely to take the vaccine was made up of those aged 65+ (78.7%), followed by 25 to 34 year olds (73.5%) and 16 to 24 year olds (70.8%). The age groups most sceptical about taking the vaccine were made up of respondents aged 50 to 64 years old (68%) and 35 to 49 years old (65%).</p>
<p>Vaccine willingness also correlated with education levels. The study found that respondents who never went to school or only received a primary level of education were 100% and 80% likely to take the vaccine, when compared to the 68.4% of people who received a secondary education, 67.1% who received a post-secondary education and 58.1% who possess a Diploma-level education.</p>
<p>Vaccine willingness was once again on the rise amongst respondents who received a tertiary or post-tertiary education. Of those respondents with a bachelor’s degree, 76.1% said they were likely to take the vaccine and of those with a post-graduate degree, 78.4% reported they were likely to get vaccinated.</p></div>
			</div>
			</div>
				
				
				
				
			</div>
				
				
			</div>
<p>The post <a href="https://esprimi.eu/2020/12/28/nearly-4-in-5-maltese-nationals-intend-to-take-the-covid-19-vaccine/">Nearly 4 in 5 Maltese nationals intend to take the COVID-19 vaccine</a> appeared first on <a href="https://esprimi.eu">Esprimi</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Get on the (omni)bus</title>
		<link>https://esprimi.eu/2014/10/09/getontheomnibus/</link>
					<comments>https://esprimi.eu/2014/10/09/getontheomnibus/#respond</comments>
		
		<dc:creator><![CDATA[Esprimi]]></dc:creator>
		<pubDate>Thu, 09 Oct 2014 10:13:36 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Cost-Effective]]></category>
		<category><![CDATA[Esprimi]]></category>
		<category><![CDATA[Market Research]]></category>
		<category><![CDATA[Omnibus]]></category>
		<guid isPermaLink="false">https://esprimi.wpenginepowered.com/?p=1</guid>

					<description><![CDATA[<p>Market research is more accessible than ever Agencies tasked with market research projects by businesses invariably create a research project specifically for the client and adopt a timeline specifically for the project. It is a method which works perfectly for complex, lengthy questionnaires or studies that require a very specific target audience. Sometimes, however, it [&#8230;]</p>
<p>The post <a href="https://esprimi.eu/2014/10/09/getontheomnibus/">Get on the (omni)bus</a> appeared first on <a href="https://esprimi.eu">Esprimi</a>.</p>
]]></description>
										<content:encoded><![CDATA[<h4><span style="color: #e91b23;"><strong>Market research is more accessible than ever</strong></span></h4>
<p>Agencies tasked with market research projects by businesses invariably create a research project specifically for the client and adopt a timeline specifically for the project. It is a method which works perfectly for complex, lengthy questionnaires or studies that require a very specific target audience.</p>
<p>Sometimes, however, it may not be necessary for businesses to take such a specific approach.</p>
<p>At times, businesses need opinions and information about the markets in which they operate without too many complexities in a relatively short timeframe, and at accessible pricing. Businesses sometimes struggle to answer just a few questions which would not justify the cost of wide-ranging, ad-hoc research.</p>
<p>Esprimi, BLM’s market research arm, has addressed this need with a new service – the omnibus study. This service provides a research tool which enables organisations to pitch in a number of research questions. The resulting questionnaire includes various topics or issues submitted by organisations operating in different sectors. It is not necessary for the questions to be related in any way.</p>
<p>The most distinct advantage of this methodology is cost-sharing. The costs relating to sampling and screening of respondents are shared among participating organisations without compromising the confidentiality of results. Clients only have access to the replies to their own questions. None of the information collected using the common tool are disseminated to other participants in the Omnibus study.</p>
<p>The omnibus research sample typically involves 400 members of the public, featuring a balanced mix of age, gender, socio-economic classification and residence profiles. The Esprimi omnibus takes place once every two months and can be carried out by phone or online interiews.</p>
<p>Omnibus surveys are commonly used for marketing performance measurement, market share analysis and brand tracking as well as brand awareness and brand sentiment research. Esprimi’s team experts help to optimise question structure to avoid bias and ambiguity.</p>
<h4>For information about how the Esprimi Omnibus research tool can benefit your business, e-mail info@esprimi.eu or call 2247 0730.</h4>
<p>&nbsp;</p>
<p>The post <a href="https://esprimi.eu/2014/10/09/getontheomnibus/">Get on the (omni)bus</a> appeared first on <a href="https://esprimi.eu">Esprimi</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://esprimi.eu/2014/10/09/getontheomnibus/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
